Summit Investment Advisors Inc. Buys 795 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Summit Investment Advisors Inc. grew its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 6.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,519 shares of the biopharmaceutical company’s stock after acquiring an additional 795 shares during the period. […]
Summit Investment Advisors Inc. grew its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 6.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,519 shares of the biopharmaceutical company’s stock after acquiring an additional 795 shares during the period. […]
